Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Myriad Genetics

WKN: 897518 / Symbol: MYGN / Name: Myriad Genetics / Aktie / Ausrüstung & Versorgung / Mid Cap /

4,71 €
-1,36 %

Genetic Technologies Ltd.

WKN: 893882 / Symbol: GNTLF / Name: Genetic / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /

0,049 €
164,86 %

Atossa Genetics Inc

WKN: A2JJ99 / Symbol: ATOS / Name: Atossa Genetics / Aktie / Ausrüstung & Versorgung / Micro Cap /

0,48 €
-5,22 %

Fulgent Genetics Inc

WKN: A2AS4N / Symbol: FLGT / Name: Fulgent Genetics / Aktie / Ausrüstung & Versorgung / Micro Cap /

17,30 €
-1,16 %

Genetic Analysis As

WKN: A3C4C1 / Name: Genetic Analysis As / Aktie / ? /

0,044 €
5,80 %

Sophia Genetics S.a.

WKN: A3CVT8 / Name: Sophia Genetics S.a. / Aktie / ? /

4,90 €
-1,21 %

Applied Genetic Technologies Corp.

WKN: A110V2 / Symbol: AGTC / Name: AGTC / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

0,37 €
-0,82 %

Lumos Pharma Inc.

WKN: A2P12E / Symbol: NLNK / Name: Lumos Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

4,16 €
-0,49 %

FDA Accepts BridgeBio's Filing for Rare Genetic Disease DrugPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
FDA Accepts BridgeBio's Filing for Rare Genetic Disease Drug

BridgeBio Pharma BBIO announced that the FDA has accepted its regulatory filing seeking approval for the investigational oral candidate encaleret to treat individuals living with a rare genetic

Seagen Inc.

WKN: A2QFAQ / Symbol: SGEN / Name: Seagen / Aktie / Biotechnologie & medizinische Forschung / Large Cap /

210,40 €
-0,85 %

miRagen Therapeutics Inc

WKN: A2QJB7 / Name: miRagen Therapeutics / Aktie / Small Cap /

16,54 €
-4,59 %

Vyant Bio Inc.

WKN: A3DZJZ / Symbol: VYNT / Name: Vyant Bio / Aktie / Anbieter & Dienstleistungen / Micro Cap /

0,13 €
-

HRMY vs. AMGN: Which Stock Is the Better Value Option?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
HRMY vs. AMGN: Which Stock Is the Better Value Option?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Harmony Biosciences Holdings, Inc. (HRMY) and Amgen (AMGN). But which of these two companies is the best

Is This the Right Time to Hold MYGN Stock in Your Portfolio?
Is This the Right Time to Hold MYGN Stock in Your Portfolio?

Myriad Genetics, Inc. MYGN is well-placed for growth in the coming quarters due to its steady rollout of new testing panels and product enhancements. The company is also progressing in its Cancer

AWHL vs. MYGN: Which Women's Health Diagnostics Stock is Better Now?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
AWHL vs. MYGN: Which Women's Health Diagnostics Stock is Better Now?

Specialty molecular diagnostics companies continue to operate in an evolving healthcare environment driven by advances in genetic testing, precision medicine and increasing demand for specialized

EXEL vs. ILMN: Which Stock Is the Better Value Option?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
EXEL vs. ILMN: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Exelixis (EXEL) and Illumina (ILMN). But which of these two stocks is more attractive to value

Generix

WKN: A0MYAC / Name: Generix / Aktie / Software & Informationsdienstleistungen / Small Cap /

9,60 €
0,42 %